Skip to content
Governance Register

Company · London

Ascend Advanced Therapies Limited

Manufacture of pharmaceutical preparations

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Ascend Advanced Therapies Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 11

  1. Errett Wesley Mcconnell Iii 2024-2025 Director View profile
  2. Justin Wesley Kern 2024-2024 Director View profile
  3. Michael Anthony Stella 2023-2026 Director View profile
  4. Andrey Kozlov 2023-2024 Director View profile
  5. Dr Andrew Sinclair 2023-2024 Director View profile
  6. Balaji Muralidhar 2023-2024 Director View profile
  7. Eric Norio Shiozaki 2023-2024 Director View profile
  8. Michael Charles Beecham 2023-2024 Director View profile
  9. Andrew Paul May 2022-2023 Director View profile
  10. Fred Cohen 2021-2024 Director View profile
  11. Dr Timothy Michael Funnell 2021-2024 Director View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Manufacture of pharmaceutical preparations; Research and experimental development on biotechnology
Incorporated
22/06/2021
Registered office
London
Previous names
Ascend Gene and Cell Therapies LTD (until 03/03/2024)
Gctx Basecamp UK LTD (until 11/08/2021)

Ownership

Owned by (3) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Ascend Advanced Therapies Limited is controlled by Timothy Michael Funnell
    Evidence
    ceased 25-50% shares, 25-50% voting, appoints directors · notified 2021-06-22, ceased 2021-12-29 · source: Companies House PSC register

Ultimately controlled by Timothy Michael Funnell.

2 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Financials

Net assets
£51,819,329
Total assets
£54,114,899
Cash
£21,248,607
Employees
27
Turnover
Not reported (small or micro-entity accounts)
Profit/loss
-£22,417,689

Five-year trend

Period endingTurnoverNet assets
2024-12-31Not reported£51,819,329
2024-12-31Not reported£51,819,329

Figures from accounts filed at Companies House (iXBRL), period ending 2024-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

1 directors on the board

0.5y median 0.5y
average tenure
0.5y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

First-time (1)

0
also govern a charity

Left in the last 12 months

Gaps to watch

  • A single director - no second pair of eyes on any decision

Where to look Suggested search: a second director to remove single-point control.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
13471083
Status
Active
Type
Private Limited Company
Accounts next due
31/12/2026
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data